Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies.
about
A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumorsPhase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumorsPhase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentAcquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASA multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.Review: ototoxic characteristics of platinum antitumor drugs.A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
P2860
Q33405390-22800F53-F49D-4BEA-A63F-CF67AE015100Q34725699-CB479A88-6EB5-47DC-B9AA-9E97ABE7D5A9Q35118358-23B6C22E-7141-465D-B8CD-9BC9FCFEF067Q35958048-9EE67A29-403D-4875-9226-D19F01EC4104Q36278738-939BC10E-7348-4F81-94ED-68886FAE8BDAQ36467960-66D19325-4233-4031-8A62-9CD5CAE41E11Q38050374-B06BCD5E-9EAE-4BA1-8108-48DE3BC02BDAQ38961012-6C062B62-406A-4925-AED0-4E7C8A4920BC
P2860
Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@ast
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@en
type
label
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@ast
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@en
prefLabel
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@ast
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@en
P2093
P356
P1476
Phase I study of weekly oxalip ...... pediatric solid malignancies.
@en
P2093
Anne Le Bouil
Birgit Geoerger
Didier Frappaz
Fabienne Pichon
Gilles Vassal
Hervé Rubie
Jean-Claude Gentet
Judith Landman-Parker
Michele Mayer
Pascal Chastagner
P304
P356
10.1200/JCO.2008.16.7585
P407
P50
P577
2008-09-01T00:00:00Z